• by bcarlson@marketresearch.com
  • April 28 2016


Abbott Adds Patient Monitoring Strength With St. Jude Buy

Abbott Adds Patient Monitoring Strength With St. Jude Buy
While Abbott’s purchase of St. Jude Medical will notably expand Abbott’s reach in heart devices, it also places Abbott into patient monitoring. Patient monitoring is one of the fastest growing device areas, with double-digit growth expected the next 5 years, according to Kalorama Information’s report, Advanced Remote Patient Monitoring 

Abbott Laboratories agreed to acquire St. Jude Medical Inc. in a cash-and-stock deal valued at $25 billion that would create one of the leading makers of heart-related devices. St. Jude Medical offers medical products in six major product segments  ICD systems, Atrial fibrillation, vascular, Pacemakers, Structural heart products.  

In terms of patient monitors, St. Jude offers the Confirm Implantable Cardiac Monitor (ICM) that consists of an implantable device and a handheld external device for event data storage. This system is a diagnostic tool for abnormal heart rhythms.  The Accel and Promote Accel pacemaker devices were approved by the FDA in February 2010, and received CE Mark approval in 2009. The pacemakers use the company’s InvisiLink Wireless Telemetry using a remote wand with the Merlin@home
transmitter and Merlin.net Patient Care Network (PCN), for daily remote monitoring and follow-up.

More products could be on the way.   The company has invested over a half million dollars in R&D activies each year.  There are 910 patents in the U.S. database under the St Jude Medical name, 310 of which contain the term "monitoring." All of the company patents were issued between 1976 and 2015. Patented technologies include cardiovascular devices, implantables, sutures, fixation systems, and sensors.  

The move also puts Abbott into the top of cardiological diagnostics and generally as one of the top medical device companies.   It also provides needed momentum as the company’s planned acquisition of Alere has stalled due to an investigation into foreign corruption over payments in Africa, Asia and Latin America.